{"id":"mmc-in-glaucoma-filtering-surgery","safety":{"commonSideEffects":[{"rate":null,"effect":"Corneal epithelial toxicity"},{"rate":null,"effect":"Hypotony (excessive intraocular pressure reduction)"},{"rate":null,"effect":"Bleb-related infection / endophthalmitis"},{"rate":null,"effect":"Cataract progression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mitomycin C is an antiproliferative agent that cross-links DNA and suppresses fibroblast activity at the surgical site. By reducing postoperative scarring and fibrosis of the filtering bleb, MMC helps maintain long-term patency and efficacy of the surgical drainage pathway, thereby sustaining intraocular pressure reduction.","oneSentence":"MMC (mitomycin C) inhibits fibroblast proliferation and collagen synthesis to prevent scarring after glaucoma filtering surgery.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:21:57.171Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Glaucoma filtering surgery (adjunctive intraoperative use to reduce postoperative scarring)"}]},"trialDetails":[{"nctId":"NCT07496957","phase":"NA","title":"Preserflo MicroShunt Versus Trabeculectomy","status":"RECRUITING","sponsor":"Medical University of Bialystok","startDate":"2026-03-01","conditions":"GLAUCOMA 1, OPEN ANGLE, D (Disorder)","enrollment":100},{"nctId":"NCT07350200","phase":"NA","title":"XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications During a Long-Term Follow-Up","status":"COMPLETED","sponsor":"Military Institute od Medicine National Research Institute","startDate":"2014-12-02","conditions":"Glaucoma","enrollment":150},{"nctId":"NCT07152132","phase":"NA","title":"SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients","status":"RECRUITING","sponsor":"Minia University","startDate":"2025-07-20","conditions":"Glaucoma, Open Angle","enrollment":50},{"nctId":"NCT04727411","phase":"NA","title":"Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery Outcomes","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2021-01-01","conditions":"Glaucoma, Glaucoma Open-Angle Primary","enrollment":39},{"nctId":"NCT03548805","phase":"NA","title":"Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma","status":"COMPLETED","sponsor":"L.V. Prasad Eye Institute","startDate":"2018-08-16","conditions":"Open Angle Glaucoma","enrollment":30},{"nctId":"NCT00666237","phase":"PHASE4","title":"Primary Tube Versus Trabeculectomy Study","status":"COMPLETED","sponsor":"University of Miami","startDate":"2008-04-01","conditions":"Glaucoma","enrollment":242},{"nctId":"NCT03480711","phase":"NA","title":"Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma","status":"COMPLETED","sponsor":"Rehab mahmoud abdelhamid mohamed","startDate":"2018-07-10","conditions":"Primary Open-angle Glaucoma","enrollment":40},{"nctId":"NCT04970251","phase":"NA","title":"Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma","status":"COMPLETED","sponsor":"Siriraj Hospital","startDate":"2018-11-01","conditions":"Intraocular Pressure, Neovascular Glaucoma, Vascular Endothelial Growth Factor Overexpression","enrollment":5},{"nctId":"NCT01922154","phase":"PHASE4","title":"Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma","status":"COMPLETED","sponsor":"Siriraj Hospital","startDate":"2009-02","conditions":"Glaucoma, Neovascular","enrollment":15},{"nctId":"NCT00444080","phase":"NA","title":"Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2006-10","conditions":"Glaucoma","enrollment":120},{"nctId":"NCT04515017","phase":"","title":"Evaluation of Filtering Bleb After Glaucoma Surgery by AS-OCTA","status":"UNKNOWN","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2020-09-01","conditions":"Trabeculectomy","enrollment":50},{"nctId":"NCT00626782","phase":"PHASE2, PHASE3","title":"Lucentis Versus Mitomycin C During Glaucoma Surgery","status":"COMPLETED","sponsor":"Wills Eye","startDate":"2008-01","conditions":"Glaucoma","enrollment":24},{"nctId":"NCT02406833","phase":"PHASE1","title":"Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy","status":"COMPLETED","sponsor":"Isarna Therapeutics GmbH","startDate":"2015-04","conditions":"Primary Open Angle Glaucoma","enrollment":13},{"nctId":"NCT01440751","phase":"PHASE4","title":"Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery","status":"COMPLETED","sponsor":"Aeon Astron Europe B.V.","startDate":"2011-09","conditions":"Glaucoma","enrollment":99},{"nctId":"NCT03293251","phase":"","title":"Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-08-01","conditions":"Outcomes of Trabeculectomy With MMC","enrollment":70},{"nctId":"NCT00524758","phase":"PHASE3","title":"Oculusgen (Ologen) Glaucoma MMC Control in Estonia","status":"COMPLETED","sponsor":"Pro Top & Mediking Company Limited","startDate":"2007-07","conditions":"Open Angle Glaucoma, Angle Closure Glaucoma, Uveitis Glaucoma","enrollment":20},{"nctId":"NCT02989207","phase":"NA","title":"Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans","status":"UNKNOWN","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2016-08","conditions":"Primary Open Angle Glaucoma","enrollment":60},{"nctId":"NCT02901236","phase":"PHASE2, PHASE3","title":"Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma","status":"COMPLETED","sponsor":"Athens Vision Eye Institute","startDate":"2014-01","conditions":"Glaucoma","enrollment":40},{"nctId":"NCT00901108","phase":"PHASE3","title":"Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma","status":"TERMINATED","sponsor":"University of Alberta","startDate":"2009-11","conditions":"Open Angle Glaucoma","enrollment":19},{"nctId":"NCT02088528","phase":"NA","title":"The Ghana Primary Tube Versus Trabeculectomy Study","status":"UNKNOWN","sponsor":"Tema Christian Eye Center","startDate":"2014-03","conditions":"Glaucoma","enrollment":298},{"nctId":"NCT01228799","phase":"NA","title":"Trabeculectomy Versus Canaloplasty","status":"COMPLETED","sponsor":"University Eye Hospital, Würzburg","startDate":"2010-06","conditions":"Glaucoma, Canaloplasty, Trabeculectomy","enrollment":64},{"nctId":"NCT00854256","phase":"NA","title":"Trabeculectomy Versus Canaloplasty to Treat Glaucoma","status":"UNKNOWN","sponsor":"University of Cologne","startDate":"2009-04","conditions":"Glaucoma","enrollment":60},{"nctId":"NCT01633775","phase":"","title":"Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Glaucoma","status":"COMPLETED","sponsor":"Vanak Eye Surgery Center","startDate":"2007-12","conditions":"Refractory Primary Open Angle Glaucoma","enrollment":100},{"nctId":"NCT00538590","phase":"PHASE4","title":"Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery","status":"COMPLETED","sponsor":"Pro Top & Mediking Company Limited","startDate":"2007-07","conditions":"Open Angle Glaucoma","enrollment":20},{"nctId":"NCT00472810","phase":"PHASE3","title":"Ologen (OculusGen)-Glaucoma MMC Control in Pakistan","status":"COMPLETED","sponsor":"Pro Top & Mediking Company Limited","startDate":"2007-03","conditions":"Glaucoma, Trabeculectomy","enrollment":40},{"nctId":"NCT00449098","phase":"PHASE4","title":"Ologen (OculusGen)-Glaucoma MMC Control Trial in India","status":"UNKNOWN","sponsor":"Pro Top & Mediking Company Limited","startDate":"2007-01","conditions":"Glaucoma","enrollment":40},{"nctId":"NCT01174420","phase":"NA","title":"Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany","status":"UNKNOWN","sponsor":"Aeon Astron Europe B.V.","startDate":"2009-11","conditions":"Open-angle Glaucoma","enrollment":40},{"nctId":"NCT00597181","phase":"PHASE4","title":"A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy","status":"TERMINATED","sponsor":"Indiana University","startDate":"2007-11","conditions":"Glaucoma","enrollment":40},{"nctId":"NCT00698438","phase":"PHASE4","title":"Comparison Of Trabeculectomy Versus The Ex-PRESS Miniature Glaucoma Device In The Same Patient: A Prospective Randomized Study","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2005-03","conditions":"Glaucoma","enrollment":30},{"nctId":"NCT00468429","phase":"PHASE4","title":"Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery","status":"UNKNOWN","sponsor":"Grewal Eye Institute","startDate":"2007-05","conditions":"Glaucoma","enrollment":40},{"nctId":"NCT00347789","phase":"","title":"Effectiveness of a Procedure for Previously Failed Glaucoma Surgery","status":"COMPLETED","sponsor":"Glaucoma Research & Education Group","startDate":"1997-05","conditions":"Glaucoma","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":51,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mitomycin C"],"phase":"phase_3","status":"active","brandName":"MMC in glaucoma filtering surgery","genericName":"MMC in glaucoma filtering surgery","companyName":"Pro Top & Mediking Company Limited","companyId":"pro-top-mediking-company-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MMC (mitomycin C) inhibits fibroblast proliferation and collagen synthesis to prevent scarring after glaucoma filtering surgery. Used for Glaucoma filtering surgery (adjunctive intraoperative use to reduce postoperative scarring).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}